Article Information
History
- November 16, 2024.
Article Versions
- Version 1 (November 13, 2024 - 08:38).
- Version 2 (November 15, 2024 - 06:08).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David M Cash*,#,1,2,
- Katy E Morgan*,3,
- Antoinette O’Connor1,
- Thomas D Veale1,
- Ian B Malone1,
- Teresa Poole3,
- Tammie LS Benzinger4,
- Brian A Gordon4,5,
- Laura Ibanez6,7,
- Yan Li6,
- Jorge J. Llibre-Guerra6,
- Eric McDade6,
- Guoqiao Wang6,
- Jasmeer P Chhatwal8,
- Gregory S Day9,
- Edward Huey10,
- Mathias Jucker11,12,
- Johannes Levin13,14,15,
- Yoshiki Niimi16,
- James M Noble17,
- Jee Hoon Roh18,
- Racquel Sánchez-Valle19,
- Peter R Schofield20,21,
- Randall J Bateman5,6,22,
- Chris Frost3,†,
- Nick C Fox†,1,2,
- The Dominantly Inherited Alzheimer Network (DIAN)
- 1Dementia Research Centre, UCL Queen Square Institute of Neurology, London UK
- 2UK Dementia Research Institute
- 3London School of Hygiene and Tropical Medicine, London UK
- 4Department of Radiology. Washington University School of Medicine, St. Louis MO
- 5Knight Alzheimer Disease Research Center, Washington University School of Medicine, St Louis, Missouri, USA
- 6Department of Neurology, Washington University in St Louis, St Louis, MO, USA
- 7Department of Psychiarty, Washington University in St Louis, St Louis, MO, USA
- 8Brigham and Women’s Hospital; Massachusetts General Hospital; Harvard Medical School, Boston, MA
- 9Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
- 10Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, RI
- 11Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, D-72076, Tübingen, Germany
- 12German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- 13Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany
- 14German Center for Neurodegenerative Diseases (DZNE), Munich, Germany;
- 15Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 16Unit for early and exploratory clinical development, The University of Tokyo Hospital, Tokyo, Japan
- 17Department of Neurology, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, GH Sergievksy Center, Columbia University, New York, NY
- 18Departments of Neurology and Physiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea
- 19Alzheimer’s disease and other cognitive disorders group. Hospital Clínic de Barcelona. FRCB-IDIBAPS. University of Barcelona, Barcelona, Spain
- 20Neuroscience Research Australia, Sydney Australia
- 21School of Biomedical Sciences, University of New South Wales, Sydney Australia
- 22Hope Center for Neurological Disorders, Washington University in St Louis, St Louis, MO, USA
- ↵#Corresponding author: d.cash{at}ucl.ac.uk
Posted November 16, 2024.
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer’s disease
